76 related articles for article (PubMed ID: 9387273)
1. [The effects of growth factors on gene expressions in human ovarian cancer cell line HO-8910].
Chen X; Dai H; Wei L
Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):351-5. PubMed ID: 9387273
[TBL] [Abstract][Full Text] [Related]
2. Growth regulation of ovarian cancer cell line HO-8910 by transforming growth factor beta 1 in vitro.
Chen X; Zheng S; Gao Y; Dai H; Mou H; Yang H
Chin Med J (Engl); 1998 Jun; 111(6):546-50. PubMed ID: 11245077
[TBL] [Abstract][Full Text] [Related]
3. Effect of epidermal growth factor/transforming growth factor alpha and transforming growth factor beta 1 on growth in vitro of rat urinary bladder carcinoma cells.
Kawamata H; Azuma M; Kameyama S; Nan L; Oyasu R
Cell Growth Differ; 1992 Nov; 3(11):819-25. PubMed ID: 1467309
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the involvement of transforming growth factor alpha and epidermal growth factor receptor autocrine growth mechanism in primary human ovarian cancers in vitro.
Morishige K; Kurachi H; Amemiya K; Fujita Y; Yamamoto T; Miyake A; Tanizawa O
Cancer Res; 1991 Oct; 51(19):5322-8. PubMed ID: 1717146
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta 1 (TGF-beta 1) inhibits growth of a human ovarian carcinoma cell line (OVCCR1) and is expressed in human ovarian tumors.
Jozan S; Guerrin M; Mazars P; Dutaur M; Monsarrat B; Cheutin F; Bugat R; Martel P; Valette A
Int J Cancer; 1992 Nov; 52(5):766-70. PubMed ID: 1330935
[TBL] [Abstract][Full Text] [Related]
6. Involvement of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vitro.
Morishige K; Kurachi H; Amemiya K; Adachi H; Inoue M; Miyake A; Tanizawa O; Sakoyama Y
Cancer Res; 1991 Nov; 51(21):5951-5. PubMed ID: 1718591
[TBL] [Abstract][Full Text] [Related]
7. [Growth regulation of human ovarian cancer cells by growth factors in vitro].
Chen X; Gao Y; Sun Y
Zhonghua Fu Chan Ke Za Zhi; 1996 Dec; 31(12):740-3. PubMed ID: 9387517
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta differentially modulates epidermal growth factor-mediated increases in leukemia-inhibitory factor, IL-6, IL-1 alpha, and IL-1 beta in human thymic epithelial cells.
Schluns KS; Cook JE; Le PT
J Immunol; 1997 Mar; 158(6):2704-12. PubMed ID: 9058804
[TBL] [Abstract][Full Text] [Related]
9. [Induction of apoptosis in human ovarian cancer cell line HO-8910 by transforming growth factor beta 1].
Chen X; Mou H; Dai H
Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):436-9. PubMed ID: 9639734
[TBL] [Abstract][Full Text] [Related]
10. [Gene expression of growth factors, growth factor receptor and oncogenes in human lung cancer cell lines].
Chen J; Liu T; Cui Q
Zhonghua Bing Li Xue Za Zhi; 1995 Feb; 24(1):25-8. PubMed ID: 7781111
[TBL] [Abstract][Full Text] [Related]
11. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
Baldwin RL; Tran H; Karlan BY
Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
[TBL] [Abstract][Full Text] [Related]
12. Involvement of HB-EGF and EGF receptor transactivation in TGF-beta-mediated fibronectin expression in mesangial cells.
Uchiyama-Tanaka Y; Matsubara H; Mori Y; Kosaki A; Kishimoto N; Amano K; Higashiyama S; Iwasaka T
Kidney Int; 2002 Sep; 62(3):799-808. PubMed ID: 12164862
[TBL] [Abstract][Full Text] [Related]
13. Gene structure and expression analysis of the epidermal growth factor receptor, transforming growth factor-alpha, myc, jun, and metallothionein in human ovarian carcinomas. Classification of malignant phenotypes.
Bauknecht T; Angel P; Kohler M; Kommoss F; Birmelin G; Pfleiderer A; Wagner E
Cancer; 1993 Jan; 71(2):419-29. PubMed ID: 8422634
[TBL] [Abstract][Full Text] [Related]
14. Anomalies of the TGF-beta postreceptor signaling pathway in ovarian cancer cell lines.
Hu W; Wu W; Nash MA; Freedman RS; Kavanagh JJ; Verschraegen CF
Anticancer Res; 2000; 20(2A):729-33. PubMed ID: 10810347
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of epidermal growth factor, transforming growth factor, and c-erbB2 in ovarian cancer.
Balcan E; Demirkiran F; Aydin Y; Sanioglu C; Bese T; Arvas M; Akçay T; Cift T
Int J Gynecol Cancer; 2012 Sep; 22(7):1138-42. PubMed ID: 22914212
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta mRNA expression and growth control of human ovarian carcinoma cells.
Bartlett JM; Rabiasz GJ; Scott WN; Langdon SP; Smyth JF; Miller WR
Br J Cancer; 1992 May; 65(5):655-60. PubMed ID: 1586592
[TBL] [Abstract][Full Text] [Related]
17. [Gene expression of TGF alpha, TGF beta 1 and C-erbB2 oncogene in human pancreatic carcinoma cell lines].
Chen J
Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):275-8. PubMed ID: 7909745
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta (TGF beta) inhibits TGF alpha expression in bovine anterior pituitary-derived cells.
Mueller SG; Kudlow JE
Mol Endocrinol; 1991 Oct; 5(10):1439-46. PubMed ID: 1723143
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta negatively modulates proliferation and c-fos expression of the human endometrial adenocarcinoma cell line HEC-1-A.
Bergman CA; Talavera F; Christman GM; Baker VV; Roberts JA; Menon KM
Gynecol Oncol; 1997 Apr; 65(1):63-8. PubMed ID: 9103392
[TBL] [Abstract][Full Text] [Related]
20. Modulation of EGF receptor protooncogene expression by growth factors and hormones in human breast carcinoma cells.
Fernandez-Pol JA
Crit Rev Oncog; 1991; 2(2):173-85. PubMed ID: 1677274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
